Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab Safety and Activity in Indian Subjects with Metastatic Colorectal Cancer
NCT02301962Phase 4Unknown
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jul 2015
- Primary completion
- Jun 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of panitumumab in metastatic colorectal cancer (mCRC), sponsored by Dr. Reddy's Laboratories. Status: unknown.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02301962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301962.